HealthcareServices

Global Respiratory Disease Testing Industry Trends and Market Forecast 2026–2030

March 2, 2026March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the respiratory disease testing market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Respiratory Disease Testing Market show for the 2026–2030 period?

The respiratory disease testing market size has shown strong growth in recent years. It is projected to increase from $3.74 billion in 2025 to $3.94 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.3%. This historical expansion can be attributed to the rising incidence of chronic respiratory diseases, improvements in hospital diagnostic capabilities, increased awareness regarding early disease detection, the widespread adoption of spirometry testing, and enhanced healthcare screening initiatives.

The respiratory disease testing market is projected to experience substantial expansion in the coming years, reaching a valuation of $4.93 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.8%. This growth during the forecast period is fueled by several factors, including a heightened demand for swift and precise respiratory diagnostic solutions, increased capital allocation towards diagnostic infrastructure, the proliferation of home-based respiratory testing options, the escalating integration of AI-powered diagnostic instruments, and a greater emphasis on managing population health. Key trends anticipated over the forecast period encompass a growing uptake of early diagnostic testing solutions, an increase in the application of in-vitro diagnostic tests for respiratory conditions, the expanding incorporation of digital tools for pulmonary monitoring, a wider availability of point-of-care respiratory testing, and a reinforced commitment to preventive respiratory care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10304&type=smp

What Drivers Are Shaping The Development Of The Respiratory Disease Testing Market?

The increasing prevalence of respiratory diseases is set to drive the respiratory disease testing market forward. These diseases are medical conditions affecting the respiratory system, including the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. Respiratory disease testing is primarily utilized for the early detection and diagnosis of these conditions, leading to earlier treatment and management. This early intervention can prevent disease progression, control the spread of infectious respiratory diseases, and reduce the risk of complications. For instance, in June 2025, the Office for Health Improvement and Disparities (OHID), a UK-based government department, reported a 7% increase in the rate of emergency admissions for respiratory disease in England from the financial year ending 2023 to the financial year ending 2024. Thus, the rising incidence of respiratory diseases acts as a significant driver for the respiratory disease testing market.

What Segment Types Are Examined In The Respiratory Disease Testing Market?

The respiratory disease testing market covered in this report is segmented –

1) By Test Type: Imaging Tests, Mechanical Tests, In-Vitro Diagnostic Tests

2) By Products: Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, Other Products

3) By Application: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Applications

4) By End-User: Hospitals, Physician clinics, Clinical laboratories, Other End-Users

Subsegments:

1) By Imaging Tests: X-rays, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans

2) By Mechanical Tests: Spirometry, Peak Flow Measurement, Lung Volume Measurement, Diffusion Capacity Tests

3) By In-Vitro Diagnostic Tests: PCR Tests, Antigen Tests, Antibody Tests, Culture Tests

How Are Emerging Trends Affecting The Progression Of The Respiratory Disease Testing Market?

Leading firms in the respiratory disease testing market are concentrating on creating sophisticated offerings, like pulmonary function testing, to secure a market advantage. These assessments, known as pulmonary function tests, encompass various evaluations that gauge lung efficiency and an individual’s respiratory capacity. As an illustration, Vitalograph Ltd., a UK-based supplier of respiratory diagnostics, introduced VitaloPFT in March 2023. The VitaloPFT Series provides sophisticated respiratory diagnostic capabilities by offering diverse and comprehensive pulmonary function testing selections. It presents a budget-friendly option for healthcare providers seeking advanced respiratory diagnostics, empowering them to provide superior care. Its design includes an intuitive interface and is user-friendly, streamlining the PFT procedure for medical professionals, thereby ensuring ease of operation and navigation.

Who Are The Top-Performing Companies In The Respiratory Disease Testing Market In Recent Years?

Major companies operating in the respiratory disease testing market are Medtronic plc, Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Masimo Corporation, Hamilton Medical AG, Drägerwerk AG & Co. KGaA, Schiller AG, Nonin Medical Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/respiratory-disease-testing-global-market-report

Which Region Currently Holds The Largest Share Of The Respiratory Disease Testing Market?

North America was the largest region in the respiratory disease testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in the respiratory disease testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Respiratory Disease Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10304&type=smp

Browse Through More Reports Similar to the Global Respiratory Disease Testing Market 2026, By The Business Research Company

Respiratory Devices And Equipment Therapeutic And Diagnostic Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

Respiratory Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-monitoring-devices-global-market-report

Respiratory Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795